vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $158.6M, roughly 1.0× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 3.4%, a 67.8% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 20.1%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $2.5M).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
BTM vs STOK — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $158.6M |
| Net Profit | $5.5M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 7.3% | 70.2% |
| Net Margin | 3.4% | 71.2% |
| Revenue YoY | 20.1% | 3661.1% |
| Net Profit YoY | 690.4% | 528.0% |
| EPS (diluted) | $0.08 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $162.5M | — | ||
| Q2 25 | $172.1M | — | ||
| Q1 25 | $164.2M | $158.6M | ||
| Q4 24 | — | $22.6M | ||
| Q3 24 | $135.3M | — | ||
| Q2 24 | $163.1M | — | ||
| Q1 24 | $138.5M | — | ||
| Q4 23 | $148.4M | — |
| Q3 25 | $5.5M | — | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $4.2M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $-939.0K | — | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-1.5M | — | ||
| Q4 23 | $-8.3M | — |
| Q3 25 | 7.3% | — | ||
| Q2 25 | 9.2% | — | ||
| Q1 25 | 10.8% | 70.2% | ||
| Q4 24 | — | -60.4% | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 0.5% | — | ||
| Q4 23 | 2.6% | — |
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.6% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | -0.7% | — | ||
| Q2 24 | -1.6% | — | ||
| Q1 24 | -1.1% | — | ||
| Q4 23 | -5.6% | — |
| Q3 25 | $0.08 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.20 | $1.90 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.25 | — | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $274.8M |
| Total DebtLower is stronger | $67.5M | — |
| Stockholders' EquityBook value | $21.0M | $350.1M |
| Total Assets | $125.3M | $406.9M |
| Debt / EquityLower = less leverage | 3.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $59.3M | — | ||
| Q2 25 | $48.0M | — | ||
| Q1 25 | $35.0M | $274.8M | ||
| Q4 24 | — | $128.0M | ||
| Q3 24 | $32.2M | — | ||
| Q2 24 | $43.9M | — | ||
| Q1 24 | $42.2M | — | ||
| Q4 23 | $29.8M | — |
| Q3 25 | $67.5M | — | ||
| Q2 25 | $66.5M | — | ||
| Q1 25 | $56.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $37.6M | — | ||
| Q4 23 | $22.5M | — |
| Q3 25 | $21.0M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $-4.6M | $350.1M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | $-7.9M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $5.0M | — | ||
| Q4 23 | — | — |
| Q3 25 | $125.3M | — | ||
| Q2 25 | $109.1M | — | ||
| Q1 25 | $89.7M | $406.9M | ||
| Q4 24 | — | $271.6M | ||
| Q3 24 | $87.4M | — | ||
| Q2 24 | $97.5M | — | ||
| Q1 24 | $90.1M | — | ||
| Q4 23 | $74.3M | — |
| Q3 25 | 3.21× | — | ||
| Q2 25 | 14.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.27× | — | ||
| Q1 24 | 7.54× | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $131.8M |
| Free Cash FlowOCF − Capex | $2.5M | $131.7M |
| FCF MarginFCF / Revenue | 1.6% | 83.0% |
| Capex IntensityCapex / Revenue | 2.5% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.20× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $6.6M | — | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $16.3M | $131.8M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $5.8M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $1.3M | — | ||
| Q4 23 | $7.5M | — |
| Q3 25 | $2.5M | — | ||
| Q2 25 | $9.8M | — | ||
| Q1 25 | $15.9M | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | $-1.0M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $789.0K | — | ||
| Q4 23 | — | — |
| Q3 25 | 1.6% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | 9.7% | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 0.6% | — | ||
| Q4 23 | — | — |
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 0.4% | — | ||
| Q4 23 | — | — |
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 3.88× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
